These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31820437)

  • 41. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
    Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
    Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.
    Bogen DL; Perel JM; Helsel JC; Hanusa BH; Thompson M; Wisner KL
    Breastfeed Med; 2011 Dec; 6(6):377-84. PubMed ID: 21348770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gender and NAS: does sex matter?
    Holbrook A; Kaltenbach K
    Drug Alcohol Depend; 2010 Nov; 112(1-2):156-9. PubMed ID: 20576365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome.
    Maalouf FI; Cooper WO; Slaughter JC; Dudley J; Patrick SW
    J Pediatr; 2018 Aug; 199():151-157.e1. PubMed ID: 29754866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children.
    Ward RM; Drover DR; Hammer GB; Stemland CJ; Kern S; Tristani-Firouzi M; Lugo RA; Satterfield K; Anderson BJ
    Paediatr Anaesth; 2014 Jun; 24(6):591-601. PubMed ID: 24666686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
    Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
    Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home.
    Johnson PN; Harrison DL; Castro CH; Miller JL
    Res Social Adm Pharm; 2012; 8(5):455-63. PubMed ID: 22222345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Triple Aim for Neonatal Abstinence Syndrome.
    Patrick SW
    J Pediatr; 2015 Dec; 167(6):1189-91. PubMed ID: 26454574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.
    Sarkar S; Donn SM
    J Perinatol; 2006 Jan; 26(1):15-7. PubMed ID: 16355103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
    Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
    J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Conventional Opioids.
    Hall ES; Rice WR; Folger AT; Wexelblatt SL
    Am J Perinatol; 2018 Mar; 35(4):405-412. PubMed ID: 29112997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of methadone dose regimen on neonatal abstinence syndrome.
    McCarthy JJ; Leamon MH; Willits NH; Salo R
    J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal Abstinence Syndrome Management: A Review of Recent Evidence.
    Grossman M; Seashore C; Holmes AV
    Rev Recent Clin Trials; 2017; 12(4):226-232. PubMed ID: 28814260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
    McPherson C
    Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal methadone treatment and neonatal abstinence syndrome.
    Liu WF; Singh K; Faisal M; Li S
    Am J Perinatol; 2015 Sep; 32(11):1078-86. PubMed ID: 25915141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Social Ecological Examination of Factors That Influence the Treatment of Newborns With Neonatal Abstinence Syndrome.
    Marcellus L
    J Obstet Gynecol Neonatal Nurs; 2018 Jul; 47(4):509-519. PubMed ID: 29763579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
    Brown MS; Hayes MJ; Thornton LM
    J Perinatol; 2015 Apr; 35(4):278-83. PubMed ID: 25357093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
    McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
    Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.